Product Information
CAVERJECT IMPULSE 20 MCG KIT is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $106.2377 per EA under NDC 00009518201. Its NADAC has been published 146 times since Dec 20, 2023.
FDA first approved this application on Jun 11, 2002.
Strength
20 ug/.5mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009518201
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVERNOUS
Effective Date
9/23/2026
Active Ingredients
ALPROSTADILApproval Type
New Drug (NDA)
FDA Application
NDA021212FDA Approved
6/11/2002
On Market Since
6/11/2002
Pharmacological Classes
Price Statistics
The NADAC for CAVERJECT IMPULSE 20 MCG KIT has been published 146 times since Dec 20, 2023, and over the history we have for it it has risen 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $106.2377 per EA |
|---|---|
| All-time high | $106.3389 (May 13, 2026) |
| All-time low | $100.3842 (Dec 20, 2023) |
| 52-week high | $106.3389 |
| 52-week low | $101.0089 |
| Median price | $101.5939 |
| Average price | $102.7189 |
| Largest weekly change | +5.0% (Dec 31, 2025) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alprostadil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alprostadil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAVERJECT IMPULSE 20 MCG KIT?
The current National Average Drug Acquisition Cost (NADAC) for CAVERJECT IMPULSE 20 MCG KIT, manufactured by Pharmacia & Upjohn Company LLC, is $106.2377 per EA (NDC 00009518201), effective Sep 30, 2026.
How has the price of CAVERJECT IMPULSE 20 MCG KIT changed over time?
Over the history we have for it, the NADAC for CAVERJECT IMPULSE 20 MCG KIT has risen 5.8%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for CAVERJECT IMPULSE 20 MCG KIT?
Since Dec 20, 2023, the NADAC for CAVERJECT IMPULSE 20 MCG KIT has ranged from a low of $100.3842 (Dec 20, 2023) to a high of $106.3389 (May 13, 2026), with a median of $101.5939 per EA.
Are there cheaper alternatives to CAVERJECT IMPULSE 20 MCG KIT?
No other NADAC-published product currently shares the active ingredient and strength of CAVERJECT IMPULSE 20 MCG KIT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CAVERJECT IMPULSE 20 MCG KIT?
CAVERJECT IMPULSE 20 MCG KIT (NDC 00009518201) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.